News

PipelineReview.com5h
NYB.AI and Pnaseer Inc. Announce Strategic Partnership to Apply AI in Hair Follicle Regeneration Research
I NYB.AI and Pnaseer Inc. (Pnaseer) have announced a strategic partnership to accelerate the discovery of compounds that promote ...
PipelineReview.com5h
SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V
I SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and ...
PipelineReview.com5h
Celltrion USA announces U.S. launch of denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo)
JERSEY CITY, NJ, USA I July 7, 2025 I Celltrion USA today announced that STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo), biosimilars referencing ...
PipelineReview.com5h
Novartis receives approval for first malaria medicine for newborn babies and young infants
BASEL, Switzerland I July 8, 2025 I Novartis today announced Coartem® (artemether-lumefantrine) Baby has been approved by Swissmedic as the first malaria ...
PipelineReview.com21h
Agenus’ BOT/BAL Achieves 42% Two-Year Survival in Refractory MSS CRC, Advances Toward Registration with FDA Alignment on Phase 3
LEXINGTON, MA, USA I July 07, 2025 I Agenus Inc. (Nasdaq: AGEN) a leader in immuno-oncology innovation, today announced that its botensilimab and balstilimab ...